Skip to main content
. 2016 Aug 1;7(37):59158–59172. doi: 10.18632/oncotarget.10993

Table 1. Clinicopathological characteristics.

Biomarker Tot (n = 170)
Gender F 87 (51.2%)
M 83 (48.8%)
Median Age ≤ 60 80 (47.1%)
> 60 90 (52.9%)
Istotype FL 70 (41.2%)
DLBCL 100 (58.8%)
DLBCL sub-type non-GCB 53 (53%)
GBC 47 (47%)